Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Definiens Extends Functionality of Leading Image and Data Analysis Solutions for Digital Pathology

Published: Monday, May 13, 2013
Last Updated: Monday, May 13, 2013
Bookmark and Share
New product portfolio release significantly reduces hands-on time for tissue-based research.

Definiens announced at the 4th International Definiens Symposium on Harvard Medical School campus the launch of new software that improves productivity in tissue-based research and biomarker development. The new software extends the functionality of Definiens’ existing product portfolio and provides a significant quality control advantage, with up to a two-fold reduction in hands on time for researchers.

Inspired by customer feedback, the software removes a number of bottlenecks in the research process and features end-to-end workflow support from initial image analysis to final results. The efficient whole-slide review along with the smooth integration of image analysis and data mining capabilities significantly reduces hands-on time, increases productivity and accelerates the development of tissue-based biomarkers.

“The latest release of Definiens’ product suite represents the first end-to-end software solution for tissue-based research,” said Kai Hartmann, Director Product Marketing Life Sciences of Definiens. “Definiens customers can now experience the entire workflow process from digital image and metadata to the final result. We are dedicated to continually learn from our users and the discussions at the Symposium are a prime opportunity to obtain inspiration for ongoing product development.”

This latest version of Definiens’ product portfolio is being released at the 4th International Definiens Symposium taking place at the Joseph B. Martin Conference Center on Harvard Medical School campus in Boston, May 13-15, 2013. The Symposium is an annual event featuring more than 20 expert presenters, and represents a unique forum for thought leaders in digital pathology and tissue-based biomarker development to discuss the latest trends in quantitative research and cutting-edge biomedical image and data analysis. The event brings together experts from around the world to share best practices and learn from their approaches and experiences.

“As the leader in image and data analysis solutions for digital pathology, we are proud to be part of the impressive advances in disease diagnosis and patient outcomes being discussed at the 4th International Definiens Symposium,” said Thomas Heydler, CEO of Definiens. “The presentations and discussions highlight that image and data analysis expertise has become the definitive advantage in biomarker development and cancer biology.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Definiens Secures € 15 Million for Tissue Phenomics-based Cancer Diagnostics
Big data approach bridges the gap between genomics and personalized medicine.
Saturday, June 28, 2014
Definiens Expands Management Team to Develop the Clinical Market
Company announces appointment of Pablo Jordan and Rebecca Berghorn.
Tuesday, October 29, 2013
Definiens Appoints Chief Marketing Officer, Merrilyn Datta, Ph.D.
Dr. Datta brings a wealth of experience in marketing and her expertise will be critical as Definiens expands its leadership in the life sciences and tissue diagnostics industries.
Tuesday, April 09, 2013
Definiens Establishes Advisory Board
Renowned industry experts to advise Definiens on clinical digital pathology market.
Thursday, March 28, 2013
Definiens Appoints Dr. Gerald Möller as Chairman of its Supervisory Board
Definiens AG announced that Dr. Gerald Möller, has joined the company's supervisory board as an independent member and has been appointed chairman.
Thursday, November 15, 2012
Definiens Closes €10 Million Round to Grow its Clinical Digital Pathology Business
The financing was led by new investor Gilde Healthcare Partners, a transatlantic investment firm with €450 million under management, focusing on the private healthcare sector.
Tuesday, October 02, 2012
Definiens Strengthens Leadership with Key Appointment
Former Aperio executive and digital pathology market expert, Dr. Martin Stuart, joins executive team.
Thursday, February 02, 2012
Definiens Digital Pathology Software Utilized for Hamner Institutes Liver Toxicology Study
Definiens TissueStudio™ and Definiens developer XD help quantify changes in apoptosis in the liver following chemical exposure.
Monday, June 07, 2010
Definiens Image Analysis Technology Improves Accuracy in Scoring Her2/neu in Breast Cancer Biopsies
New multi-dimensional image analysis platform aids diagnosis and treatment of breast cancer.
Wednesday, June 03, 2009
Definiens and Bioscan Team Up for Cooperative Marketing Efforts
Under the terms of the agreement, the companies will offer integrated solutions for intelligent small animal imaging analysis.
Wednesday, December 03, 2008
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
The MaxSignal Colistin ELISA Test Kit from Bioo Scientific
Kit can help prevent the antibiotic apocalypse by keeping last resort drugs out of the food supply.
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Biologists Induce Flatworms to Grow Heads and Brains of Other Species
Findings shed light on role of a new kind of epigenetic signaling in evolution, could yield clues for understanding birth defects and regeneration.
Fat Cells Originating from Bone Marrow Found in Humans
Cells could contribute to diabetes, heart disease.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos